AzTrials
AzTrials

Bone InjuryNCT05440435

Application of Mobile DR in the Diagnosis of Bone Trauma in High Cold Environment

An observational study of Bone Injury and Artificial Intelligence, run by Rongrong Hua at 4 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the high cold environment, mobile digital radiography (DR) is used to collect the imaging of bone injury patients, and the artificial intelligence diagnosis module is used to diagnose the injury. Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Bone Injury, Artificial Intelligence
What is being tested?
digital radiography (DR)
How many people
2,000 participants
Where
4 sitesChina
Study dates
1 Jan 2022to 31 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: The population in the surrounding areas of the five centers set up in this study.

Who may be able to join

  • Patients with new bone injury

Who cannot join

  • Life threatening.
  • Head injury and fracture.
  • There are congenital malformations in the bone injury site.

Trial locations and contacts

4 sites in 1 country.

Rongrong Hua, Doctor contact

0086-15810159356

huarongrong1011@163.com

China4 sites, 4 recruiting
  • Center A

    Beijing, Beijing Municipality

    Rongrong Hua, Dr., +8615810159356, huarongrong1011@163.com

    Recruiting
  • Xucheng He

    Neimeng

    Xucheng He

    Recruiting
  • Center C

    Xinjiang

    Xucheng He

    Recruiting
  • Center

    Xizang

    Xucheng He

    Recruiting

Other trials in China

About this study

In the high cold environment, mobile digital radiography (DR) is used to collect the imaging of bone injury patients, and the artificial intelligence diagnosis module is used to diagnose the injury. The quality of images obtained by mobile or conventional DR and the consistency between artificial intelligence and pure artificial diagnosis will be analyzed respectively. Finally, the application value of mobile DR loaded with artificial intelligence diagnosis function in high cold environment is determined.

Being tested
digital radiography (DR)
Keywords
Artificial intelligence, Digital radiography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • digital radiography (DR)Diagnostic test

    Patients with bone injury received routine and mobile DR sequential examination.

Study groups in NCT05440435
Study groupRoleWhat they receive
Center AStudy center A that observe cohort populations (sample size=400).
Receives: Diagnostic Test: digital radiography (DR)
Center BStudy center B that observe cohort populations (sample size=400).
Receives: Diagnostic Test: digital radiography (DR)
Center CStudy center C that observe cohort populations (sample size=400).
Receives: Diagnostic Test: digital radiography (DR)
Center DStudy center D that observe cohort populations (sample size=400).
Receives: Diagnostic Test: digital radiography (DR)
Center EStudy center E that observe cohort populations (sample size=400).
Receives: Diagnostic Test: digital radiography (DR)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The image quality rating scale score.

    There are 24 entries in the image quality rating scale with a total score of 100 points. According to the score, there are 4 grades (A. ≥90; B. 80-89; C. 70-79; D. <70), among which D is unqualified.

    Measured: Immediately after inclusion in the study.

  2. Difference of fracture detection rate (sensitivity and specificity) between artificial intelligence and expert diagnosis.

    Sensitivity is the percentage of individuals with bone injury who diagnosed by artificial intelligence or experts. Specificity is the percentage of those without bone injury who have normal diagnosis results.

    Measured: Immediately after the diagnosis is completed.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2022
  2. Study start1 Jan 2022
  3. Primary completion1 Oct 2022 (estimated)
  4. Study completion31 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05440435
Sponsor's protocol ID
DR001
Status last verified
Sep 2022
First submitted
24 Jun 2022
Last updated
19 Sep 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bone Injury and Artificial Intelligence, run by Rongrong Hua at 4 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rongrong Hua, Doctor (0086-15810159356, huarongrong1011@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The image quality rating scale score. (time frame: Immediately after inclusion in the study.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in